Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Dow
Boehringer Ingelheim
Medtronic
Mallinckrodt

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Litigation Details for CELGENE CORPORATION v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

CELGENE CORPORATION v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)

Docket   Start Trial Date Filed 2018-09-27
Court District Court, D. New Jersey Date Terminated 2019-02-08
Cause 15:1126 Patent Infringement Assigned To Esther Salas
Jury Demand None Referred To Michael A. Hammer
Parties CELGENE CORPORATION; TEVA PHARMACEUTICAL INDUSTRIES LIMITED; TEVA PHARMACEUTICALS USA, INC.
Patents 9,993,467
Attorneys BRIAN JOHN FORSATZ; CHARLES MICHAEL LIZZA; CHRISTINE INTROMASSO GANNON; DAVID LEIGH MOSES; ELEONORE OFOSU-ANTWI; FRANK CHARLES CALVOSA; LIZA M. WALSH; SARAH ANN SULLIVAN; WILLIAM C. BATON
Firms Quinn Emanuel Uquhart & Sullival LLP; Quinn Emanuel Urquhart & Sullivan LLC; Saul Ewing Arnstein & Lehr LLP
Link to Docket External link to docket
Small Molecule Drugs cited in CELGENE CORPORATION v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for CELGENE CORPORATION v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 expiration of United States Patent No. 9,993,467 (the “’467 patent” or “the patent-in-suit”) owned by Celgene… 1. This is an action for patent infringement under the patent laws of the United States, 35 … The Patent-in-Suit 6. On June 12, 2018, the United States Patent and Trademark…of the ’467 patent, constitutes infringement of one or more of the claims of that patent under 35 U.S.C…infringement of any claim of the patent-in-suit, until after the expiration of the patent-in-suit, or any later External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Merck
Express Scripts
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.